Plain-English translation of NCT06356272 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for biological markers — measurable signs in your blood or saliva — that appear when oropharyngeal cancer is present and disappear when it's gone or never develop in healthy people. This observational study doesn't test a new medication, but rather helps Mayo Clinic understand what happens in the body during and after cancer treatment so they can develop better detection tools in the future.
Currently, doctors need to rely on imaging and biopsies to detect oropharyngeal cancer and monitor whether treatment is working. A simple blood or saliva test could help catch the disease earlier and track how well treatment is working, potentially saving lives.
You likely qualify if…
You likely don't qualify if…
You will have blood and saliva samples collected before and after your cancer treatment, complete questionnaires about your health, and allow researchers to review your medical records. You'll need to visit Mayo Clinic Rochester in person for at least three appointments total — one before treatment starts and at least two follow-up visits during your standard cancer care. The study involves observation only; you won't receive any new medication or treatment as part of this research.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States